Rebecca L. Roberts

Dunedin, OTA, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

A Case of Acute Generalised Exanthematous Pustulosis Following Ocrelizumab for Multiple Sclerosis.

A Case of Acute Generalised Exanthematous Pustulosis Following Ocrelizumab for Multiple Sclerosis.

Journal: The Australasian journal of dermatology

Published: November 12, 2025

Online monitoring of higher alcohols and esters throughout beer fermentation by commercial Saccharomyces cerevisiae and Saccharomyces pastorianus yeast.

Online monitoring of higher alcohols and esters throughout beer fermentation by commercial Saccharomyces cerevisiae and Saccharomyces pastorianus yeast.

Journal: Journal of mass spectrometry : JMS

Published: January 28, 2023

ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.

ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.

Journal: Drug metabolism and pharmacokinetics

Published: July 04, 2018

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: January 03, 2018

Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin.

Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin.

Journal: PeerJ

Published: August 21, 2017

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.

Journal: Rheumatology (Oxford, England)

Published: June 27, 2017

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.

Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.

Journal: Therapeutic drug monitoring

Published: November 18, 2016

Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.

Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.

Journal: Nature genetics

Published: August 01, 2016

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.

Journal: The pharmacogenomics journal

Published: August 12, 2015

Update on thiopurine pharmacogenetics in inflammatory bowel disease.

Update on thiopurine pharmacogenetics in inflammatory bowel disease.

Journal: Pharmacogenomics

Published: June 13, 2015

A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout.

A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout.

Journal: Pharmacogenetics and genomics

Published: June 08, 2015

Pharmacogenetic considerations in the treatment of gout.

Pharmacogenetic considerations in the treatment of gout.

Journal: Pharmacogenomics

Published: April 17, 2015

Showing 1-12 of 39

Last Updated: 09/26/2026